LycoRed gets new patent
This article was originally published in The Tan Sheet
Executive Summary
LycoRed, Ltd., Israel receives patent protection from the United States Office of Patents and Trademarks for an invention based on phytoene and phytofluene, carotenoids found in natural tomato extract, that effectively inhibits the progression of atherosclerosis, a degenerative disease affecting arterial health, the firm announces Sept. 2. LycoRed asserts the research supporting the patent shows the carotenoids, alone, together and in combination with other tomato carotenoids, inhibits the deposition of place from oxidized LDL cholesterol, the main cause of atherosclerosis
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.